Prenetics Group Limited (PRE): Price and Financial Metrics

Prenetics Group Limited (PRE): $5.94

0.01 (-0.17%)

POWR Rating

Component Grades








PRE Price/Volume Stats

Current price $5.94 52-week high $14.55
Prev. close $5.95 52-week low $2.85
Day low $5.94 Volume 349
Day high $5.94 Avg. volume 82,493
50-day MA $5.19 Dividend yield N/A
200-day MA $5.35 Market Cap 54.27M

PRE Stock Price Chart Interactive Chart >

Prenetics Group Limited (PRE) Company Bio

Prenetics Group Limited operates as a diagnostics and genetic testing company worldwide. It develops consumer genetic testing and early colorectal cancer screening products; and provides COVID-19 testing, rapid point of care and at-home diagnostic testing, and medical genetic testing products. The company's products include CircleDNA, a consumer genetic testing offering that uses whole exome sequencing; Project Screen, a COVID-19 test; and Circle HealthPod, a molecular testing product for COVID-19. It is also developing ColoClear, a non-invasive stool-based FIT-DNA test for colorectal cancer screening; Circle SnapShot, an at-home blood test with a user-friendly blood sample collection and result delivery system; Circle Medical, a test to identify causal genetic mutations for patients; and Circle One and F1x/Fem, a DNA profile and questionnaire based personalized nutrition solution. The company was founded in 2014 and is headquartered in Quarry Bay, Hong Kong.

PRE Latest News Stream

Event/Time News Detail
Loading, please wait...

PRE Latest Social Stream

Loading social stream, please wait...

View Full PRE Social Stream

Latest PRE News From Around the Web

Below are the latest news stories about PRENETICS GLOBAL LTD that investors may wish to consider to help them evaluate PRE as an investment opportunity.

Prenetics Announces Third Quarter 2023 Financial Results

Prenetics Global Limited (NASDAQ: PRE) ("Prenetics" or the "Company"), a leading genomics-driven health sciences company, today announced financial results for the third quarter ended September 30, 2023, along with recent business updates.

Yahoo | November 20, 2023

Prenetics Global Limited (NASDAQ:PRE): Is Breakeven Near?

With the business potentially at an important milestone, we thought we'd take a closer look at Prenetics Global...

Yahoo | November 11, 2023

Prenetics Global Limited Announces Reverse Stock Split

HONG KONG, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE), a leading-genomics-driven health sciences company today announced that it will proceed with a reverse stock split of its outstanding ordinary shares at a ratio of 1-for-15. The reverse stock split is expected to become effective on or around November 13, 2023, subject to confirmation by NASDAQ. The Company’s common stock is expected to begin trading on a post-split basis at the market open on November 14, 2023 u

Yahoo | November 1, 2023

Prenetics Announces Second Quarter 2023 Financial Results

Prenetics Global Limited (NASDAQ: PRE) ("Prenetics" or the "Company"), a leading genomics-driven health sciences company, today announced financial results for the second quarter ended June 30, 2023, along with recent business updates.

Yahoo | September 15, 2023

A World's First: The Miss Hong Kong Pageant 2023 Unveiled Contestants' CircleDNA Results Live on Television

In a move that had never been seen before, marrying beauty with science, the Miss Hong Kong Pageant 2023, which just aired on TVB, had set out to revolutionize the industry by partnering with CircleDNA to unveil contestants' DNA results live on television. This ground-breaking initiative marked the first time in the history of beauty pageants worldwide that such a reveal had taken place.

Yahoo | August 29, 2023

Read More 'PRE' Stories Here

PRE Price Returns

1-mo 2.34%
3-mo 28.85%
6-mo 20.98%
1-year -55.14%
3-year N/A
5-year N/A
YTD 0.51%
2023 -80.30%
2022 N/A
2021 N/A
2020 N/A
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!